Month: April 2024

Just-the-Beginning-for-GLP-1-Costs;-Pricing,-Rebates-and-Access-to-GLP-1-Meds;-No-Increase-in-Surgical-Complications-for-those-on-GLP-1s

Just the Beginning for GLP-1 Costs; Pricing, Rebates and Access to GLP-1 Meds; No Increase in Surgical Complications for those on GLP-1s.

April 28, 2024 No Comments

AT A GLANCE Elaine Chen at STAT on new studies to suggest GLP-1 health care costs have only begun to climb. Large employers are trying to limit the costs of the expensive new generation of weight-loss drugs, from POLITICO. Delayed gastric emptying and pulmonary aspiration following induction of anesthesia in patients using GLP-1 drugs is not an issue, as per JAMA. The Kaiser Family Foundation analyzed Medicare

Read More »
Sleep Apnea Severity down by Two-Thirds with Tirzetapide; Disparities in Obesity Care; the Brozempic Era; Are Obesity Drugs Forever?

Sleep Apnea Severity down by Two-Thirds with Tirzetapide; Disparities in Obesity Care; the Brozempic Era; Are Obesity Drugs Forever?

April 21, 2024 No Comments

AT A GLANCE Eli Lilly reports Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity. Karen Kaplan at the Los Angeles Times rightly notes ‘…doctors who treat obesity… fear the medications are making this health disparity worse.’ Is the Era of ‘Brozempic’ Upon Us? asks The New York Times, with reports of some telehealth start-ups ‘…playing up

Read More »
Novo’s Semaglutide for Heart Failure; Biocon Leads India’s Generic GLP-1 Charge; I’m a Doctor on Ozempic; Cost-Effectiveness of Semaglutide Versus Endoscopic Sleeve

Novo’s Semaglutide for Heart Failure; Biocon Leads India’s Generic GLP-1 Charge; I’m a Doctor on Ozempic; Cost-Effectiveness of Semaglutide Versus Endoscopic Sleeve

April 14, 2024 No Comments

AT A GLANCE Biocon Ltd. is leading India’s push to weight loss medications as patents lapse, unleashing generic supply for the global weight-loss market, from Bloomberg. STAT News reports European regulators ‘…have found no evidence that GLP-1 drugs like Ozempic and Wegovy cause suicidal thoughts or actions.’ ‘I’m a doctor on Ozempic – it’s effective under one condition…’ says President and CEO of Philadelphia College of Osteopathic Medicine,

Read More »
Costco’s Weight Loss Program; China Develops GLP-1 Drug; Not Everyone Loses Weight on Ozempic; Weed for Weight Loss; GLP-1 For Parkinson’s

Costco’s Weight Loss Program; China Develops GLP-1 Drug; Not Everyone Loses Weight on Ozempic; Weed for Weight Loss; GLP-1 For Parkinson’s

April 7, 2024 No Comments

AT A GLANCE USA Today reports ‘…Costco and its low-cost health care partner are expanding into weight-loss management…’ Reuters notes a biosimilar version of Novo Nordisk’s popular diabetes drug Ozempic has been developed in China Sumathi Reddy at The Wall Street Journal writes some people don’t lose much weight on drugs like Ozempic. Dr. Amir Ghaferi and colleagues from Wisconsin review Metabolic Surgery for Diabetes Management

Read More »
Categories
Archives
Scroll to Top
Skip to content